General Information of This Antibody-drug Conjugate (ID: DRG0WMIKO)
ADC Name
HMPL-A251
Synonyms
HMPL-A251
   Click to Show/Hide
Organization
HUTCHMED (Originator)
Drug Status
Phase 1/2
Drug-to-Antibody Ratio
4
Antibody Name
HMA000352
 Antibody Info 
Antigen Name
Receptor tyrosine-protein kinase erbB-2 (HER2)
 Antigen Info 
Payload Name
HM5041609
 Payload Info 
Payload Target
PI3K; PIKK
 Target Info 
Linker Name
A cleavable linker
 Linker Info 
Conjugate Type
Undisclosed
2027 Update
The disease landscape of This ADC
2027 Update
The clinical trial pipelines of This ADC
Disease Name Phase 1 Phase 2 Phase 3 Approved
Unspecific solid tumor
1 Trials
Clinical trial identifier
NCT07228247; CTR20254667